RP Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,846,154	Closed	-$28.8M	–	1
2025 Q1	$28.8M	Hold	3,846,154	–	–	20.78%	3
2024 Q4	$29.2M	Hold	3,846,154	–	–	12.84%	3
2024 Q3	$29.2M	Hold	3,846,154	–	–	12.84%	3
2024 Q2	$23.8M	Hold	3,846,154	–	–	13.29%	3
2024 Q1	$19.5M	Hold	3,846,154	–	–	10.85%	2
2023 Q4	$23M	Hold	3,846,154	–	–	15.49%	2
2023 Q3	$27.2M	Hold	3,846,154	–	–	26.28%	2
2023 Q2	$27.1M	Hold	3,846,154	–	–	27.82%	2
2023 Q1	$32.1M	Hold	3,846,154	–	–	44.43%	2
2022 Q4	$44.2M	Hold	3,846,154	–	–	52%	1
2022 Q3	$48.5M	Hold	3,846,154	–	–	22.39%	2
2022 Q2	$40.7M	Hold	3,846,154	–	–	16.31%	3
2022 Q1	$62.5M	Hold	3,846,154	–	–	25.84%	2
2021 Q4	$43M	Buy	+3,846,154	New	+$50.9M	18.49%	2